We found that MKI reverses the castration-resistant phenotype of CRPC tumors in vivo, by altering the transcriptional effects of castration on both tumor and stromal genes, whereas prolonged administration of a CDK8/19i induces tumor regression and cures. Here, CDK8 is linked to neoplasm.